Clinical trials for Autosomal dominant generalized epidermolysis bullosa simplex, intermediate form

2 recruiting or active trials synced from ClinicalTrials.gov.

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

RECRUITINGPhase 2NCT06509984
A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized
Centre Hospitalier Universitaire de Nice
ACTIVE NOT RECRUITINGPHASE2, PHASE3NCT06073132
An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)
TWi Biotechnology, Inc.

More about Autosomal dominant generalized epidermolysis bullosa simplex, intermediate form